Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

NCT01338025 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

33

Enrollment

NETWORK

Sponsor class

Stopped Study was halted for lack of accrual

Conditions

HIV Disease

Interventions

DRUG: HAART regimen
DRUG: 3TC or FTC monotherapy

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Collaborators

[object Object]
[object Object]